Download Free Technical Assistance To The Greater Mekong Subregion For Strengthening Malaria Control For Ethnic Minorities Financed By The Poverty Reduction Cooperation Fund Book in PDF and EPUB Free Download. You can read online Technical Assistance To The Greater Mekong Subregion For Strengthening Malaria Control For Ethnic Minorities Financed By The Poverty Reduction Cooperation Fund and write the review.

The World Health Organization's Global Technical Strategy for Malaria 2016- 2030 has been developed with the aim to help countries to reduce the human suffering caused by the world's deadliest mosquito-borne disease. Adopted by the World Health Assembly in May 2015 it provides comprehensive technical guidance to countries and development partners for the next 15 years emphasizing the importance of scaling up malaria responses and moving towards elimination. It also highlights the urgent need to increase investments across all interventions - including preventive measures diagnostic testing treatment and disease surveillance- as well as in harnessing innovation and expanding research. By adopting this strategy WHO Member States have endorsed the bold vision of a world free of malaria and set the ambitious new target of reducing the global malaria burden by 90% by 2030. They also agreed to strengthen health systems address emerging multi-drug and insecticide resistance and intensify national cross-border and regional efforts to scale up malaria responses to protect everyone at risk.
Malaria control was identified as one of the main priorities in the Greater Mekong Subregion (GMS). Malaria is one of the major diseases undermining the health of ethnic minorities. Approximately one third of ethnic minorities, about seven million people, live in remote, often hilly and forested, parts of these countries. Many are also more vulnerable due to lack of education, poor health status, lack of formal land ownership, and in general not being familiar with the ways of the modern world. The most vulnerable among all these groups are pregnant women, young children, and very poor and malnourished people. Although the malaria situation in the Mekong region has improved over the past several years, it is widely recognized that ethnic minorities, migrants and forest workers remain at high risk for malaria. They often live in remote areas with weak or without public health systems, and lack physical, social and financial access to preventive and curative care.
Malaria prevention and control are major foreign assistance objectives of the U.S. Government (USG). In May 2009, President Barack Obama announced the Global Health Initiative (GHI), a comprehensive effort to reduce the burden of disease and promote healthy communities and families around the world. Through the GHI, the United States will help partner countries improve health outcomes, with a particular focus on improving the health of women, newborns, and children. The President's Malaria Initiative (PMI) is a core component of the GHI, along with HIV/AIDS and tuberculosis. PMI was launched in June 2005 as a five-year, $1.2 billion initiative to rapidly scale up malaria prevention and treatment interventions and reduce malaria-related mortality by 50% in 15 high-burden countries in sub-Saharan Africa. With passage of the 2008 Lantos-Hyde Act, funding for PMI was extended and, as part of the GHI, the goal of PMI was adjusted to reduce malaria-related mortality by 70% in the original 15 countries by the end of 2015. In addition, PMI will work to limit the spread of antimalarial drug resistance in two USAID-supported regional programs, the Mekong Regional Initiative in six Southeast Asian countries and the Amazon Malaria Initiative in seven South American countries. In line with the 2009 Lantos-Hyde Malaria Strategy, PMI support extends to the Greater Mekong Sub-Region (GMS), which is made up of six countries: Burma, Cambodia, China (Yunnan Province), Lao People's Democratic Republic, Thailand, and Vietnam. Although considerable progress has been made in malaria control in the GMS during the past 10 years, malaria remains a major concern for the international community, ministries of health, and the people of the region. This is due primarily to the development and possible spread of resistance to artemisinin drugs, the principal component of the combination therapies for malaria that now are the first-line treatment for malaria throughout the GMS and the world. Plasmodium falciparum resistance to artemisinin drugs has now been confirmed in western Cambodia; failures in artemisinin-based combination therapy (ACT) have been reported from multiple sites on the Thai-Cambodian border; and an early warning sign of artemisinin resistance - prolongation of parasite clearance times - has been reported from the Thailand-Burma and Burma-China borders and in southern Vietnam. The USG has supported malaria control efforts in the GMS since 2000. These regional efforts have focused on antimalarial drug resistance monitoring and drug quality surveillance. All countries in the GMS have Global Fund to Fight AIDS, Tuberculosis, and Malaria (Global Fund) support. Burma and Cambodia received Round 9 Global Fund malaria grants, and Thailand's Round 10 malaria grant has been approved. The other major source of funding for artemisinin resistance containment in Burma is the multi-donor initiative, Three Millennium Development Goal Fund, formerly known as the Three Diseases Fund. In addition, Global Fund announced a new three-year $100 million initiative for regional efforts to reduce malaria transmission and respond to resistance in GMS countries.